Table 1

Subtypes of lymphomas (n = 6,382)

Age (year)

Sex

Site




Subtype

No.

Median

Range

Male

Female

M:F

Nodal

Extranodal

N/E


DLBCL

2288

55

3-93

1359

929

1.5

1027

1261

0.81

ENKTCL

949

41

1-82

668

281

2.4

32

917

0.03

MALT

350

56

16-86

183

167

1.1

20

330

0.06

FL

327

54

23-83

213

114

1.9

292

35

8.34

LBL

301

19

1-71

211

90

2.3

253

48

5.27

CLL/SLL

256

60

22-88

180

76

2.4

228

28

8.14

PTCL, NOS

221

55

12-90

148

73

2

152

69

2.2

ALCL

196

27.5

4-71

118

78

1.5

151

45

3.36

AITL

185

61

20-86

124

61

2

185

0

-

MCL

175

61

20-79

132

43

3.1

126

49

2.57

Burkitt

106

15.5

2-69

78

28

2.8

49

57

0.86

SPTCL

54

33

4-68

25

29

0.9

0

54

0

LPL

44

61

30-82

25

19

1.3

34

10

3.4

PCCD30LD

37

37

2-78

18

19

0.9

0

37

-

SMZBCL

20

61.5

15-76

10

10

1

20

0

-

HSTCL

14

25

11-46

9

5

1.8

5

9

0.56

MF/SS

14

52.5

31-80

8

6

1.3

0

14

-

ETCL

7

29

17-42

5

2

2.5

0

7

-

NMZBCL

5

64

52-80

3

2

1.5

5

0

-

MC-CHL

606

31

3-89

433

173

2.5

597

9

66.3

NS-CHL

145

29

3-76

75

70

1.1

139

6

23.2

LR-CHL

35

30

4-64

29

6

4.8

35

0

-

LD-CHL

12

53

19-82

6

6

1

12

0

-

NLPHL

35

36

8-74

25

10

2.5

34

1

34


Total

6382

50

1-93

4085

2297

1.8

3396

2986

1.1


DLBCL, diffuse large B-cell lymphoma; ENKTCL, extranodal NK/T-cell lymphoma, nasal type; MALT, extranodal marginal zone lymphoma of mucosa associated lymphoid tissue; FL, follicular lymphoma; LBL, lymphoblastic leukemia/lymphoma; CLL/SLL, chronic lymphocytic leukemia/small lymphocytic lymphoma; PTCL, NOS, peripheral T-cell lymphoma, not otherwise specified; ALCL, anaplastic large cell lymphoma; AITL, angioimmunoblastic T-cell lymphoma; MCL, mantle cell lymphoma; Burkitt, Burkitt lymphoma; SPTCL, subcutaneous panniculitis-like T-cell lymphoma; LPL, lymphoplasmacytic lymphoma; PCCD30LD, primary cutaneous CD30 positive lymphoproliferative disorders; SMZBCL, splenic marginal zone B-cell lymphoma; HSTCL, hepatosplenic T-cell lymphoma; MF/SS, mycosis fungoides/Sezary syndrome; ETCL, enteropathy-associated T-cell lymphoma; NMZBCL, nodal marginal zone B-cell lymphoma; MC-CHL, mixed cellularity classical Hodgkin lymphoma; NS-CHL, nodular sclerosis classical Hodgkin lymphoma; LR-CHL, lymphocyte-rich classical Hodgkin lymphoma; LD-CHL, lymphocyte-depleted classical Hodgkin lymphoma; NLPHL, nodular lymphocyte predominant Hodgkin lymphoma.

Yang et al. Diagnostic Pathology 2011 6:77   doi:10.1186/1746-1596-6-77

Open Data